Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
Not Confirmed
Not Confirmed
30 September-02 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Industry Trade Show
Not Confirmed
30 September-02 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
27 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/27/2954731/0/en/BridgeBio-Shares-Recurrent-Event-Analysis-of-ATTRibute-CM-Demonstrating-a-42-Reduction-by-Acoramidis-on-the-Composite-Endpoint-of-All-Cause-Mortality-and-Recurrent-Cardiovascular-r.html
17 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/17/2947311/0/en/BridgeBio-Announces-Infigratinib-Is-the-First-Ever-Investigational-Therapeutic-Option-for-Achondroplasia-to-Be-Awarded-Breakthrough-Therapy-Designation-by-the-FDA.html
10 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/10/2944157/0/en/BridgeBio-Receives-FDA-s-Regenerative-Medicine-Advanced-Therapy-RMAT-Designation-for-BBP-812-Canavan-Disease-Gene-Therapy-Program.html
10 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/10/2944156/0/en/BridgeBio-Pharma-Reports-Topline-Results-from-Phase-1-2-Trial-of-Investigational-Gene-Therapy-for-Congenital-Adrenal-Hyperplasia-CAH.html
10 Sep 2024
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/bridgebio-stop-development-therapy-genetic-disorder-2024-09-10/
06 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/06/2942094/0/en/BridgeBio-Pharma-Reports-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?